Mycogenic synthesis of copper oxide nanoparticles using response surface methodology and assessment of their biological potential

Thalaian, Nishi, Sarma, V. Venkateswara
Brazilian Journal of Microbiology · Springer Nature · 2026-10-26 · DOI: 10.1007/s42770-026-02107-3

Abstract

Endophytic fungi represent a strategic biological template for the synthesis of metallic nanomaterials with enhanced stability and biocompatibility. This study investigates the bio-assisted synthesis of copper oxide nanoparticles (B-CuO NPs) using an aqueous extract of Alternaria alternata , an endophyte isolated from the medicinal plant Phyllanthus emblica. The synthesis was achieved through a bio-inspired chemical reduction approach using sodium borohydride, where fungal secondary metabolites, profiled by Gas chromatography-mass spectrometry, acted as critical stabilizing and capping agents. For technical precision and reproducibility, the synthesis parameters were refined using Response Surface Methodology coupled with Box-Behnken design. Comprehensive physicochemical characterization confirmed the formation of stable, crystalline, phase-pure, nanosized particles with a polydispersity index of 0.242, indicative of uniform size and colloidal stability. Biological efficacy was evaluated through diverse antioxidant assays, antibacterial analysis against V. parahaemolyticus and E. coli , and safety by hemolysis testing. Results demonstrated strong radical scavenging potential, particularly in the hydroxyl assay (77.94%), and recorded inhibition zones of 24—29 mm supported by time—dependent growth kinetics. Mechanistic investigations via 2’,7’-dichlorodihydrofluorescein diacetate staining and 5,5’-dithiobis-(2-nitrobenzoic acid) assays confirmed that B-CuO NPs key contributing factors associated with oxidative stress-mediated antibacterial pathways through a significant surge in intracellular reactive oxygen species (up to 81.53%) and the subsequent depletion of reduced glutathione levels (up to 51.13%). Hemocompatibility assessment demonstrated below 9% hemolysis at 600 µg/mL, confirming safety for biomedical and intravenous applications. These findings establish Alternaria alternata —mediated B-CuO NPs as a promising, nanomaterial platform with dual antibacterial and antioxidant potential for future biomedical applications.

Read at publisher →

Similar articles